Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
AD     Remove this Ad

SOTAC PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.560.380.300.240.42

What is the latest Fixed Capital/Sales ratio of SOTAC PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of SOTAC PHARMACEUTICALS is 0.56 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.56
Mar20240.38
Mar20230.30
Mar20220.24
Mar20210.42

How is Fixed Capital/Sales of SOTAC PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.56
47.37
Mar2024 0.38
26.67
Mar2023 0.3
25.00
Mar2022 0.24
-42.86
Mar2021 0.42 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹127.7 Cr 3.6% -6.8% -17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

3.6%

-6.8%

-17.9%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses